Urological approach for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a clinical care center

References

• Sugarbaker PH. Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives? Am J Surg. 2011;201:157–159.
   PubMed Web of Science ®Google Scholar
• Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Onc. 2009;7:5.
   PubMed Web of Science ®Google Scholar
• Votanopoulos KI, Randle RW, Craven B, et al. Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2014;21:868–874.
   PubMed Web of Science ®Google Scholar
• Braam HJ, van Oudheusden TR, de Hingh IHJT, et al. Urological procedures in patients with peritoneal carcinomatosis of colorectal cancer treated with HIPEC: morbidity and survival analysis. Anticancer Res. 2015;35:295–300.
   PubMed Web of Science ®Google Scholar
• Cascales P, Gil J, Alarcón C, et al. Urinary tract surgery in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy. Cirugia Espanola. 2012;90:162–168.
   PubMed Web of Science ®Google Scholar
• Ang C, Naik R. The value of ureteric stents in debulking surgery for disseminated ovarian cancer. Int J Gynecol Cancer. 2009;19:978–980.
   PubMed Web of Science ®Google Scholar
• Beraldo S, Neubeck K, Von Friderici E, et al. The prophylactic use of a ureteral stent in laparoscopic colorectal surgery. Scand J Surg. 2013;102:87–89.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Perinectomy procedures. Ann Surg. 1995;221:29–42.
   PubMed Web of Science ®Google Scholar
• Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–74.
   PubMedGoogle Scholar
• Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–3743.
   PubMed Web of Science ®Google Scholar
• Butterworth SA, Panton ONM, Klaassen DJ, et al. Morbidity and mortality associated with intraperitoneal chemotherapy for pseudomyxoma peritonei. Am J Surg. 2002;183:529–532.
   PubMed Web of Science ®Google Scholar
• Bryant J, Clegg AJ, Sidhu MK, et al. Systematic review of the sugarbaker procedure for pseudomyxoma peritonei. Br J Surg. 2005;92:153–158.
   PubMed Web of Science ®Google Scholar
• Tentes AK, Tripsiannis G, Markakidis SK, et al. Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. Eur J Surg Oncol. 2003;29:69–73.
   PubMed Web of Science ®Google Scholar
• Honoré C, Souadka A, Goéré D, et al. HIPEC for peritoneal carcinomatosis: does an associated urologic procedure increase morbidity? Ann Surg Oncol. 2012;19:104–109.
   PubMed Web of Science ®Google Scholar
• Leapman MS, Jibara G, Tabrizian P, et al. Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched study. Ann Surg Oncol. 2014;21:1153–1158.
   PubMed Web of Science ®Google Scholar
• Smeenk RM, Bex A, Verwaal VJ, et al. Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications. J Surg Oncol. 2006;93:20–23.
   PubMed Web of Science ®Google Scholar
• Coccolini F, Lotti M, Manfredi R, et al. Ureteral stenting in cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy as a routine procedure: evidence and necessity. Urol Int. 2012;89:307–310.
   PubMed Web of Science ®Google Scholar
• Fanning J, Fenton B, Jean GM, et al. Cost analysis of prophylactic intraoperative cystoscopic ureteral stents in gynecologic surgery. J Am Osteopath Assoc. 2011;111:667–669.
   PubMedGoogle Scholar